You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Estimation of the regression coefficients

From: Determinants of new drugs prescription in the Swiss healthcare market

Variable Coefficient Standard deviation P-value 95% credible interval
Prescription-level
 Constant 2.878 0.060 0.000 2.766; 2.989
 Rx −0.656 0.004 0.000 −0.663; −0.649
 Generic drug −0.870 0.003 0.000 −0.876; −0.865
Market-level
 Number of insured −2.68e-06 1.05e-06 0.002 −4.92e-06; −6.55e-07
 Yearly treatment cost −0.0002 0.00003 0.000 −0.000202; −0.000096
 HHI 0.572 0.089 0.000 0.418; 0.753
 Number of drugs −0.0035 0.0008 0.000 −0.005; −0.002
 Number of active substances −0.045 0.012 0.000 −0.068; −0.023
Patient-level
 Age = 0-19 −0.043 0.004 0.000 −0.050; −0.035
 Age = 20-39 0.005 0.003 0.045 −0.001; 0.011
 Age = 40-59 (reference)
 Age = 60-79 0.014 0.003 0.000 0.008; 0.019
 Age = 80+ 0.016 0.004 0.000 0.008; 0.024
 Male −0.006 0.002 0.002 −0.010; −0.002
 Deductible >400 CHF 0.009 0.002 0.000 0.004; 0.014
 Co-morbidity index −0.0001 0.0003 0.345 −0.0006; 0.0004
Physician-level
 General Practitioner (ref.)
 Independent Specialist 0.034 0.004 0.000 0.027; 0.042
 Hospital 0.039 0.010 0.000 0.021, 0.057
Region-level
 Aarau (reference)
 Basel-Stadt −0.006 0.008 0.251 −0.022; 0.011
 Fribourg 0.045 0.008 0.000 0.030; 0.060
 Geneva 0.015 0.006 0.010 0.002; 0.027
 Jura 0.091 0.016 0.000 0.058; 0.123
 Neuchâtel −0.011 0.009 0.089 −0.028; 0.005
 Ticino 0.078 0.008 0.000 0.063; 0.093
 Vaud 0.021 0.006 0.000 0.008; 0.033
 Valais 0.055 0.008 0.000 0.040; 0.070
  1. Confidence intervals in squared brackets